Cardiovascular effects of sodium glucose cotransporter 2 inhibitors

Tricia Santos Cavaiola, Jeremy Pettus Division of Endocrinology and Metabolism, University of California San Diego, San Diego, CA, USA Abstract: As the first cardiovascular (CV) outcome trial of a glucose-lowering agent to demonstrate a reduction in the risk of CV events in patients with type 2 diab...

Full description

Bibliographic Details
Main Authors: Santos Cavaiola T, Pettus J
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/cardiovascular-effects-of-sodium-glucose-cotransporter-2-inhibitors-peer-reviewed-article-DMSO